At 2 a.m., an emergency physician does not ask whether the patient’s insurer has a satisfactory contract. Care happens first. The accounting arrives later, and sometimes the insurer’s payment is lower than the provider thinks the work was worth. Since 2022, many patients have been protected from being dragged into that argument by the federal No Surprises Act. The argument itself did not vanish. It moved backstage, into a timed process of negotiation and baseball-style arbitration. HaloMD sells the backstage crew.
The Addison, Texas company is neither a medical practice nor the neutral arbitrator. It is a provider-side operator. Its platform screens claims for federal or state eligibility, evaluates an insurer’s offer, assembles documentation, manages deadlines and fees, prepares a position, submits the case to a certified independent dispute resolution entity, then tracks the award and payment. People supply regulatory, legal and financial judgment; software supplies repetition, routing and memory.
That unglamorous distinction matters. Calling HaloMD “AI for medical bills” misses the useful part. A claim can fall under federal rules, a specified state law or neither. A missed deadline can end the case. The evidence changes by specialty. A hospital with a few claims might muscle through a spreadsheet. A national group with thousands needs an operating system.
The product is a clock with paperwork attached
Federal IDR begins after an insurer’s initial payment or denial and a 30-business-day open-negotiation period. If the parties still disagree, one can initiate arbitration. Each side submits a final offer; the certified decision-maker chooses one. This is why “baseball-style” is more than a cute comparison. There is no gentle compromise in the middle. Strategy means deciding what to file, where to file it, how to support the number and when to walk away.
HaloMD’s customers sit where out-of-network work is common and urgent: emergency medicine, anesthesiology, radiology, pathology, critical care, air ambulance and intraoperative neuromonitoring. The company says its clientele ranges from independent groups to hospitals and health systems. In May 2026 it reported more than 20,000 providers across every state and Washington, D.C.; weeks later, founder and president Alla LaRoque told an industry audience the count had passed 30,000. Treat both as company figures, but the direction is plain.
HaloMD is not selling arbitration. It is selling the ability to arrive prepared, over and over, before the clock runs out.
What it costs - and why the math can work
HaloMD does not publish a universal price card. One unusually revealing contract does exist. Nutex Health filed its May 2024 agreement with regulators. Under that deal, HaloMD receives 20 percent of the net uplift from an informal settlement or a state or federal arbitration award. The provider pays the CMS administrative fee and the arbitrator’s fee up front. Customized reports cost $250 an hour. The agreement is exclusive for eligible Nutex emergency-medicine claims and initially runs three years.
The contract even provides a worked example. Start with a $2,000 award. Subtract a $100 initial payment, $100 patient responsibility and a $115 administrative fee. The defined net is $1,685; HaloMD’s 20 percent is $337; the provider keeps $1,348 of that net. It is tidy on paper. In life, the result depends on eligibility, the losing-side fee, collection and how much internal labor the provider avoids.
What the customer buys is less headcount volatility. Instead of staffing for a surge, training employees on each jurisdiction and rebuilding the workflow whenever guidance changes, a practice sends HaloMD the claim data and supporting records. The public Nutex agreement shows the breadth of the handoff: HaloMD can qualify claims, negotiate with plans, choose filing timing, decide whether to batch, draft position statements, pay process fees from a client-owned operating account and reconcile receipts. Monthly reports cover pending claims, remittances, refunds, withdrawals and invoices. That is closer to an outsourced department than a software license. It also explains why replacing the vendor is harder than swapping dashboards - the customer has transferred both institutional knowledge and daily authority.
The failure that created the opening
Two things failed first. The old provider appeal route was often slow and unproductive. Then planners underestimated the new system. Federal agencies initially expected roughly 17,000 disputes a year; more than 90,000 were initiated in the portal’s first five and a half months. The volume brought queues, eligibility fights and a great deal of email. LaRoque told EDPMA that a self-managed dispute can produce roughly 17 messages, each with its own timing demands.
There was no documented consumer-style pivot or dramatic change of heart. The trigger was structural. LaRoque had spent years in out-of-network revenue-cycle management and payer relations. The No Surprises Act created a fresh legal right and a messy operating layer around it. HaloMD was founded in 2022, the year the patient protections and federal payment process took effect. The product followed the rulebook.
Scale is the moat and the controversy. A Congressional Research Service analysis found HaloMD was the top initiating party in the emergency and nonemergency category in the fourth quarter of 2024, accounting for 18 percent of disputes. In a 2026 interview, LaRoque said HaloMD had accumulated more than two million determinations and an 88 percent-plus prevailing rate. More outcomes can sharpen offer selection and specialty benchmarks. More filings can also magnify a weak eligibility rule.
Then the machine drew fire
Beginning in 2025, insurer affiliates sued HaloMD and several provider clients in federal courts. The complaints alleged that some disputes were ineligible, duplicated across state and federal systems, filed inside cooling-off periods or supported by misleading documentation. HaloMD has denied wrongdoing and framed the litigation as an attempt to avoid binding awards. These are allegations, not findings.
The outcomes are mixed and still moving. In April 2026, a California federal court dismissed Anthem Blue Cross of California’s case without leave to amend, concluding that its legal theories could not support the collateral attack it attempted. In June, Highmark filed a separate suit involving more than 450 disputes and $3.9 million in awards. HaloMD moved to dismiss in July; briefing remained open in August. A win in one courthouse does not decide the facts in another.
This is the market tension in miniature. Providers see a company enforcing a process Congress gave them. Insurers see a high-volume intermediary pushing the process beyond its proper borders. HaloMD’s value and exposure come from the same promise: it can do at scale what a practice cannot.
What a founder can steal
Follow the compulsory clock
Deadlines create pain with a budget. Map every handoff, notice and failure state before writing software.
Sell the whole outcome
A portal alone leaves work on the customer’s desk. HaloMD wraps people, process and software around the claim.
Price against recovered value
Outcome-linked fees lower the purchase barrier, but only when the uplift is measurable and collection is dependable.
Make compliance a product
In regulated workflows, throughput is not enough. Eligibility checks, audit trails and exception review deserve first-class status.
The playbook will not travel everywhere. It fails when a claim is legally ineligible, the expected uplift is smaller than administrative and decision-maker fees, the documentation is thin, or the customer already has a capable in-house team. It is fragile when rules change faster than software and operators can adapt. It is dangerous when automation turns uncertainty into confident submission. A data moat helps predict decisions; it does not make a bad claim good.
HaloMD also competes with a broad and slightly blurry set: internal revenue-cycle teams, specialist filing firms, healthcare law practices and general RCM vendors. Certified IDR entities are not competitors. They are the neutral decision-makers. HaloMD’s positioning is narrower: own the provider side of both federal and state payment arbitration, end to end.
A company built in the seam
The most interesting businesses often live between a rule and the people forced to follow it. HaloMD found such a seam. Its reported remote-first workforce grew beyond 800 people across more than 40 states by May 2026. The company won Great Place to Work certification with 89 percent employee approval and added senior leaders in technology, data, compliance, finance and government affairs. That is the org chart of a software company, a regulated services operation and a policy shop sharing one roof.
The mission is simple enough: secure fair reimbursement so providers can keep delivering care. The mechanism is anything but simple. HaloMD’s future depends on whether it can keep converting complexity into reliable outcomes while proving that industrial scale and careful compliance can coexist. The next product release matters. So does the next rule, the next audit and the next judge.